Sanofi India rose 2.08% to Rs 2,695 at 9:32 IST on BSE after net profit surged 106.92% to Rs 92.70 crore on 15.49% increase in total income from operations to Rs 488.30 crore in Q4 December 2013 over Q4 December 2012.
The company announced the results after market hours on Tuesday, 25 February 2014.
Meanwhile, the BSE Sensex was up 54.69 points, or 0.26%, to 20,907.16.
On BSE, so far 8,906 shares were traded in the counter, compared with an average volume of 2,040 shares in the past one quarter.
The stock hit a high of Rs 2,779 and a low of Rs 2,652.15 so far during the day. The stock hit a record high of Rs 2,940 on 3 December 2013. The stock hit a 52-week low of Rs 2,225 on 1 March 2013.
The stock had outperformed the market over the past one month till 25 February 2014, sliding 0.43% compared with the Sensex's 1.33% fall. The scrip had, however, underperformed the market in past one quarter, falling 0.92% as against Sensex's 1.20% rise.
The mid-cap company has an equity capital of Rs 23.03 crore. Face value per share is Rs 10.
Sanofi India's net profit jumped 50.08% to Rs 265.20 crore on 14.99% increase in total income from operations to Rs 1808.90 crore in the year ended December 2013 over the year ended December 2012.
Sanofi is one of the leading pharmaceutical companies. The company discovers, develops and distributes therapeutic solutions. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme.
Powered by Capital Market - Live News
